Tridacaine Ii Patch
Product Images NDC 73352-830

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tridacaine Ii (NDC 73352-830). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trifluent Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tridacaine 01)

FDA Label Image

Figure 1 (Tridacaine 02)

FDA Label Image

Principal Display Panel (15 Patch Pouch Label)

Principal Display Panel (15 Patch Pouch Label)
This is a description of a Lidocaine Patch 5% named Tridacaine. Each adhesive patch contains 700mg of Lidocaine USP, with 50mg per gram of adhesive in an aqueous base. The patch also includes various inactive components such as glycerin, propylene glycol, and preservatives like methylparaben and propylparaben. The usual dosage and full prescribing information can be found in the accompanying product information. The product is distributed from San Antonio, TX. This package contains 15 patches, with each patch individually enveloped.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.